Camlin Fine Sciences Ltd - 532834 - Board Meeting Intimation for Consideration And Approval Of The Audited Standalone And Consolidate Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.
Camlin Fine Sciences announced a Board Meeting on May 26, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. This meeting will finalize the company's financial performance for the last fiscal year.
May 20 2026 11:05:00
Camlin Fine Sciences Ltd - 532834 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Camlin Fine Sciences received a monitoring agency report for Q4 FY26, confirming that the funds from its Rights Issue were utilized without deviation from the stated objects. This ensures transparency in fund deployment and adherence to regulatory requirements.
May 15 2026 17:05:00
Camlin Fine Sciences Ltd - 532834 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Camlin Fine Sciences shareholders approved an Ordinary Resolution via postal ballot to increase Authorized Share Capital. The resolution passed with 99.99% votes in favor and 0.01% against, with voting concluding on May 7, 2026.
May 08 2026 15:05:00
Camlin Fine Sciences Ltd - 532834 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Camlin Fine Sciences shareholders approved an Ordinary Resolution via postal ballot to increase Authorized Share Capital. The resolution passed with 99.99% votes in favor and 0.01% against, with voting concluding on May 7, 2026.
May 08 2026 15:05:00
Camlin Fine Sciences Limited
Camlin Fine Sciences filed a draft tender offer with the French Stock Markets Authority (AMF) for the remaining shares of Vinpai. The offer is at EUR 3.60 per share, aiming for full ownership after a previous majority stake acquisition.
May 04 2026 22:05:00
Camlin Fine Sciences Ltd - 532834 - Press Release Issued By The Company.
Camlin Fine Sciences has filed a draft tender offer with the French Stock Markets Authority (AMF) to acquire the remaining shares of Vinpai at EUR 3.60 per share. This move aims to fully consolidate CFSL's ownership in Vinpai.
May 04 2026 22:05:00
Camlin Fine Sciences Limited
Infinity Direct Holdings, promoter of Camlin Fine Sciences, declared no new encumbrance on its shares for the financial year ended March 31, 2026. This regulatory filing confirms compliance with Takeover Regulations.
Apr 28 2026 17:04:00
Read More